-TIS score predicts PD-L1 response. -Typical TIS is 6-9. -RP2/nivo patient 201-4402-0005 ripped from 6.5 to 10.5. Higher than any patient in 3rd party n=58 basket study (to validate TIS) below, and higher than any patient $REPL has treated to date. https:
6,870 followers
33 followers
The tumor inflammation signature (TIS) is associated with anti-PD-1 treatment benefit in the CERTIM pan-cancer cohort. https://t.co/Iro5kdit9F https://t.co/9990MthM9g
236 followers
RT @StojdlLab: An 18-gene tumour inflammation signature (TIS) panel can predict the clinical benefit of anti-PD-1 #immune checkpoint blocka…
616 followers
An 18-gene tumour inflammation signature (TIS) panel can predict the clinical benefit of anti-PD-1 #immune checkpoint blockade: https://t.co/XyDBSHh3vm via @BioMedCentral @Inserm @UParisDescartes @HopitalCochin #cancer #immunotherapy #OA Image credit: Damo